Gelatinase expression and activity in the synovium and skin of patients with erosive psoriatic arthritis

Journal of Rheumatology

Volumn 29, Issue 1, 2002, Pages 107-117

  Hitchon, C A ^a   Danning, C L ^a   Illei, G G ^a   El Gabalawy, H S ^a   Boumpas, D T ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Arthritis; Gelatinases; Metalloendopeptidases; Psoriatic; Skin; Tissue inhibitor of metalloproteinase

Indexed keywords

GELATINASE A; INTERSTITIAL COLLAGENASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ADULT; ARTICLE; CLINICAL ARTICLE; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NEEDLE BIOPSY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIATIC ARTHRITIS; RHEUMATOID ARTHRITIS; SKIN BIOPSY; SYNOVIUM; UNITED STATES; ZYMOGRAPHY;

ADULT; ANTI-INFLAMMATORY AGENTS; ARTHRITIS, PSORIATIC; CHEMOTAXIS, LEUKOCYTE; DISEASE PROGRESSION; FEMALE; GELATINASES; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 15; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES, MEMBRANE-ASSOCIATED; METALLOENDOPEPTIDASES; MIDDLE AGED; SKIN; SYNOVIAL MEMBRANE; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 0036138771     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. Psoriatic arthritis
2. Psoriatic arthritis: Clinical features
3. Pannus and pannocytes. Alternative models of joint destruction in rheumatoid arthritis
4. Differential expression of cathepsins B and L compared with matrix metalloproteinases and their respective inhibitors in rheumatoid arthritis and osteoarthritis
5. In situ hybridization studies of stromelysin and collagenase messenger RNA expression in rheumatoid synovium
6. Expression of metalloproteinases and metalloproteinase inhibitor in human arthritis synovium
7. Matrix metalloproteinases in angiogenesis: A moving target for therapeutic intervention
8. Generation of biologically active IL-1 beta by matrix metalloproteinases: A novel caspase-1-independent pathway of IL-1 beta processing
9. Degradation of interleukin 1 beta by matrix metalloproteinases
10. Expression of matrix metalloproteinase 9 (96 kd gelatinase B) in human rheumatoid arthritis
11. Constitutive expression of a 92-kD gelatinase (type V collagenase) by rheumatoid synovial fibroblasts and its induction in normal human fibroblasts by inflammatory cytokines
12. Transforming growth factor beta 1 up-regulates type IV collagenase expression in cultured human keratinocytes
13. Post-surgical wound progression monitored by temporal changes in the expression of matrix metalloproteinase-9
14. Active synovial matrix metalloproteinase-2 is associated with radiographic erosions in patients with early synovitis
15. Gelatinase B in chronic synovitis: Immunolocalization with a monoclonal antibody
16. New collagenolytic enzymes/cascade identified at the pannus-hard tissue junction in rheumatoid arthritis: Destruction from above
17. Inhibition of interleukin 1 αinduced cartilage oligomeric matrix protein degradation in bovine articular cartilage by matrix metalloproteinase inhibitors
18. The effects of selected inhibitors of matrix metalloproteinases (MMPs) on bone resorption and the identification of MMPs and TIMP-1 in isolated osteoclasts
19. Inhibition of cartilage and bone destruction in adjuvant arthritis in the rat by a matrix metalloproteinase inhibitor
20. The codependence of angiogeneisis and chronic inflammation
21. Inhibition of angiogenesis by tissue inhibitor of metalloproteinase-3
22. Tranilast inhibits the proliferation, chemotaxis and tube formation of human microvascular endothelial cells in vitro and angiogenesis in vivo
23. Impaired endothelial ossification and angiogenesis in mice deficient in MT-MMP1
24. Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity
25. Localization of matrix metalloproteinase MMP2 to the surface of invasive cells by interaction with integrin αvβ3
26. Decreased angiogenesis and arthritic disease in rabbits treated with an αvβ3 antagonist
27. The AP-1 site and MMP gene regulation: What is all the fuss about
28. AP-1 and NF-κB regulation in rheumatoid arthritis and murine collagen-induced arthritis
29. Role of tissue inhibitor of metalloproteinase-2 (TIMP2) in regulation of progelatinase A activation catalyzed by membrane-type matrix metalloproteinase-1 (MT1-MMP) in human cancer cells
30. Mechanism of cell surface activation of 72-kDa type IV collagenase isolation of the activated form of the membrane metalloproteinase
31. Membrane type matrix metalloproteinase 1 activates progelatinase A without furin cleavage of the N-terminal domain
32. Relating matrix metalloproteinase structure to function: Why the "hemopexin" domain
33. Preferential inhibition of 72and 92-kDa gelatinases by tissue inhibitor of metalloproteinase-2
34. Matrix metalloproteinase 3 (stromelysin) activates the precurser for the human matrix metalloproteinase 9
35. Membrane type 2 matrix metalloproteinase can initiate the processing of progelatinase A and is regulated by the tissue inhibitors of matrix metalloproteinases
36. The American Rheumatology Association 1987 revised criteria for the classification of rheumatoid arthritis
37. Severe psoriasis, oral therapy with a new retinoid
38. Quantitative zymography: Detection of picogram quantities of gelatinases
39. Circulating levels of matrix metalloproteinases MMP-3, MMP-1, tissue inhibitor of metalloproteinase-1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers
40. Changes in biochemical markers of joint tissue metabolism in a randomized controlled trial of glucocorticoids in early rheumatoid arthritis
41. Gene expression (collagenase, tissue inhibitor of metalloproteinases, complement, and HLA-DR) in rheumatoid arthritis and osteoarthritis synovium: Quantitative analysis and effect of intrarticular steroids
42. Initiation of osteoclast bone resorption by interstitial collagenase
43. Bone resorption induced by parathyroid hormone is strikingly diminished in collagenase resistant mutant mice
44. Bone resorption by osteoclasts
45. Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor
46. Macrophage-derived cytokine and nuclear factor κB p65 expression in synovial membrane and skin of patients with psoriatic arthritis
47. Mice lacking beta3 integrins are osteosclerotic because of dysfunctional osteoclast
48. TNF-alpha and IL-1 beta selectively induce expression of 92-kDa gelatinase by human macrophages
49. Synergistic, additive, and antagonistic effects of interleukin-1 beta, tumor necrosis factor alpha, and gamma-interferon on prostaglandin E, hyaluronic acid, and collagenase production by cultured synovial fibroblasts
50. Patterns of cytokine production in psoriatic synovium
51. IL10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes
52. Collagenase, cathepsin B and cathepsin L gene expression in the synovial membrane of patients with early inflammatory arthritis
53. αvβ3 integrin expression in psoriatic arthritis
54. Reduced synovial membrane macrophage numbers, ELAM-1 expression and lining layer hyperplasia in psoriatic arthritis as compared with rheumatoid arthritis
55. Synovial lining, endothelial and inflammatory mononuclear cell proliferation in synovial membranes in psoriatic and reactive arthritis: A comparative quantitative morphometric study
56. Reduced angiogenesis and tumor progression in gelatinase A deficient mice
57. Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins
58. Pattern of metalloproteinase production in psoriatic synovial explant tissues
59. Upregulation of collagenase stromelysin and TIMP-1 mRNA expression in psoriatic arthritis synovium
60. Activated gelatinase-B (MMP9) and urokinase-type plasminogen activator in synovial fluids of patients with arthritis. Correlation with clinical and experimental variables of inflammation
61. Matrix metalloproteinase 2 (gelatinase A) is related to migration of keratinocytes
62. Psoralen photoactivation promotes morphological and functional changes in fibroblasts in vitro reminiscent of cellular senescence
63. Expression of serine proteinases and metalloproteinase in organ-cultured human skin. Altered levels in the presence of retinoic acid and possible relationship to retinoic acid and possible relationship to retinoidinduced loss of epidermal cohesion
64. The 72-kDa and the 92-kDa gelatinases, but not their inhibitors TIMP-1 and TIMP-2, are expressed in early psoriatic lesions
65. Human psoriatic skin in organ culture: Comparison with normal skin exposed to exogenous growth factors and effects of an antibody to the EGF receptor